Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Return on Capital %

Nymox Pharm Corp Return on Capital % Chart (NYMX)

Nymox Pharm Corp annual/quarterly Return on Capital % from 2010 to 2020.
  • Nymox Pharm Corp Return on Capital % for the quarter ending June 06, 2020 was -1,931.49 a 95.27% decrease of -1,840.11 year over year
  • Nymox Pharm Corp Return on Capital % for the last 12 months ending June 06, 2020 was -193.92 a 12.00% decrease of -23.27 year over year
  • Nymox Pharm Corp Annual Return on Capital % for 2019 was -157.18 a -47.15% increase of 74.11 from 2018
  • Nymox Pharm Corp Annual Return on Capital % for 2018 was -231.29 a 1,375.04% decrease of -3,180.26 from 2017
  • Nymox Pharm Corp Annual Return on Capital % for 2017 was 2,948.98 a 35.75% increase of 1,054.25 from 2016
Other Margins & Efficiency Metrics:
  • Nymox Pharm Corp EBITDA Margin for the quarter ending March 03, 2015 was $63m a 263.17% increase of 166m year over year
  • Nymox Pharm Corp Return on Equity % for the quarter ending September 09, 2018 was -298.46 a -11.24% increase of 33.54 year over year
View Chart On Koyfin

Quarterly NYMX Return on Capital % Data

06/2020-1,931.49
03/2020-250.90
12/2019-143.09
09/2019-91.38
06/2019-142.34
03/2019-83.81
12/2018-125.91
09/2018-187.81
06/2018-482.65
03/2018579.08

Annual NYMX Return on Capital % Data

2019-157.18
2018-231.29
20172,948.98
20161,894.73
2015479.78
201467.72
201348.07
201280.16
2011175.59
2010300.41